Resultados: 22

    ACR Appropriateness Criteria® Pretreatment evaluation and follow-up of invasive cancer of the cervix: 2023 update

    J. Am. Coll. Radiol; 21 (6S), 2024
    Cervical cancer is a common gynecological malignancy worldwide. Cervical cancer is staged based on the International Federation of Gynecology and Obstetrics (FIGO) classification system, which was revised in 2018 to incorporate radiologic and pathologic data. Imaging plays an important role in pretreatme...

    Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer

    Evidence-based recommendations on pembrolizumab (Keytruda) plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer in adults....

    KDP pro screening karcinomu hrdla děložního

    Tento klinický doporučený postup (KDP) pro screening cervikálního karcinomu představuje aspekty prevence cervikálního karcinomu, diagnostiky, léčby a následného sledování, a to do úrovně high grade preinvazivních lézí. Určující příčinou invazivního karcinomu děložního hrdla ...

    WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (‎HPV)‎

    This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. This document includes guidance on an important additional option for cervical screening, the use of mRNA (messenger RNA) HPV testing. This gives countries a...

    Should we perform cervix removal during hysterectomy for benign uterine disease? Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF)

    To provide guidelines from the French College of Obstetricians and Gynecologists (CNGOF), based on the best evidence available, concerning subtotal or total hysterectomy, for benign disease. The CNGOF has decided to adopt the AGREE II and GRADE systems for grading scientific evidence. Each recommendation...

    Guía de práctica clínica para el manejo de cáncer de cuello uterino: estadios tempranos

    El cáncer de cuello uterino o cáncer de cérvix es el cuarto cáncer más común en mujeres(1, 2). El impacto del cáncer de cuello uterino en el Perú es importante: el 14.9% de todos los casos de cáncer notificados en el periodo 2006-2011, correspondía al cáncer de cuello uterino y los departament...

    Guía de práctica clínica cáncer cérvico uterino

    Generar recomendaciones basadas en la mejor evidencia disponible acerca del tratamiento de cáncer cervicouterino. Contribuir a reducir la morbimortalidad, mejorar la sobrevida y calidad de vida por cáncer cervicouterino. Proporcionar una base científica sólida y actualizada a los equipos de salud....

    WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions

    The objectives of these guidelines are to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and to support countries to update their national guidelines for the use of thermal ablation for cervical precancer....

    WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions

    The objectives of these guidelines are: • to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and • to support countries to update their national guidelines for the use of thermal ablation for cervical precancer. These guidelines were developed using the W...

    Prevención, detección, diagnóstico y tratamiento de lesiones precursoras del cáncer del cuello cérvicouterino en primer y segundo nivel de atención

    Esta guia tiene como objetivos dismunir la incidencia de lesiones cervicales intraepiteliales y del cancer de cuello uterino a traves de estrategias preventivas en salud; Establecer los criterios de referencia para ala tencion de la mujer en servicios especializados; Disminuir la mortalidad por cancer de...